Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Canadian Immunodeficiency Research Collaborative (CIRC) is a national non-profit organization dedicated to advancing the care of patients with primary immunodeficiency (PI) and related autoinflammatory disorders. Based in Toronto, the collaborative facilitates multicenter clinical research and manages comprehensive national patient registries to track outcomes and improve treatment standards across Canada. CIRC brings together a network of leading Canadian immunologists and researchers to address unmet needs in the diagnosis and management of rare immunological conditions like Hereditary Angioedema (HAE). The organization is also instrumental in developing clinical practice guidelines and providing medical education to healthcare professionals. By fostering partnerships between academia, industry, and patient groups, CIRC accelerates the translation of scientific discoveries into improved clinical care for the immunology community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canadian Immunodeficiency Research Collaborative.